ReviewFrontiers in immunology2026

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy.

Tomasz Buczek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.